Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Legend Biotech (LEGN) Asset Utilization Ratio (2020 - 2025)

Historic Asset Utilization Ratio for Legend Biotech (LEGN) over the last 6 years, with Q3 2025 value amounting to 110.05.

  • Legend Biotech's Asset Utilization Ratio rose 14336.59% to 110.05 in Q3 2025 from the same period last year, while for Sep 2025 it was 110.05, marking a year-over-year increase of 14336.59%. This contributed to the annual value of 0.36 for FY2024, which is 9876.98% up from last year.
  • Legend Biotech's Asset Utilization Ratio amounted to 110.05 in Q3 2025, which was up 14336.59% from 113.22 recorded in Q2 2025.
  • Over the past 5 years, Legend Biotech's Asset Utilization Ratio peaked at 113.86 during Q1 2025, and registered a low of 0.0 during Q2 2021.
  • For the 5-year period, Legend Biotech's Asset Utilization Ratio averaged around 39.03, with its median value being 21.66 (2023).
  • Per our database at Business Quant, Legend Biotech's Asset Utilization Ratio plummeted by 3025.5% in 2023 and then soared by 5400499.14% in 2024.
  • Over the past 5 years, Legend Biotech's Asset Utilization Ratio (Quarter) stood at 0.09 in 2021, then increased by 25.53% to 0.12 in 2022, then surged by 36951.55% to 43.21 in 2023, then skyrocketed by 154.1% to 109.79 in 2024, then grew by 0.24% to 110.05 in 2025.
  • Its Asset Utilization Ratio was 110.05 in Q3 2025, compared to 113.22 in Q2 2025 and 113.86 in Q1 2025.